Chronic remyelination is chronic aplastic anemia, belonging to a kind of aplastic anemia. Patients with chronic remittent anemia have a slow progression of the disease, manifested by mild anemia, infection, bleeding and other symptoms, for patients with chronic remittent anemia, the first choice of drugs is cyclosporine treatment, cyclosporine is a kind of immunosuppressant, able to inhibit the human body’s cytotoxic T-lymphocyte damage to hematopoietic stem cells, so as to achieve the purpose of the treatment of chronic remittent anemia. However, cyclosporine has obvious side effects, can cause gingival hyperplasia, bleeding, liver and kidney function damage, etc., to check the liver and kidney function of the disease regularly. In addition, besides cyclosporine, androgenic drugs are also the first choice for the treatment of chronic cataracts. Androgenic drugs can stimulate bone marrow hematopoiesis, however, for female patients, androgens will have masculinizing side effects after application.